Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
about
Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays13q14 deletions in CLL involve cooperating tumor suppressorsHistone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemiaDiverse mechanisms of AKT pathway activation in human malignancyThe biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiaSuppression of survival signalling pathways by the phosphatase PHLPPMosaic 13q14 deletions in peripheral leukocytes of non-hematologic cancer cases and healthy controlsAnalysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell linesCellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.Chronic lymphocytic leukemia and 13q14: miRs and more.Evaluation of methods for amplification of picogram amounts of total RNA for whole genome expression profiling.Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks.Cell sorting-assisted microarray profiling of host cell response to Cryptosporidium parvum infection.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we goMultiplex ligation-dependent probe amplification versus multiprobe fluorescence in situ hybridization to detect genomic aberrations in chronic lymphocytic leukemia: a tertiary center experience.microRNA and cancerNF1 inactivation in adult acute myelogenous leukemiaThe impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output.Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemiaClinical and biological relevance of genomic heterogeneity in chronic lymphocytic leukemia.Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.Mislocalization of the E3 ligase, β-transducin repeat-containing protein 1 (β-TrCP1), in glioblastoma uncouples negative feedback between the pleckstrin homology domain leucine-rich repeat protein phosphatase 1 (PHLPP1) and Akt.Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.MicroRNA-3127 promotes cell proliferation and tumorigenicity in hepatocellular carcinoma by disrupting of PI3K/AKT negative regulationLong noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.Chromosome Condensation 1-Like (Chc1L) Is a Novel Tumor Suppressor Involved in Development of Histiocyte-Rich NeoplasmsThe phosphatase PHLPP1 regulates Akt2, promotes pancreatic cancer cell death, and inhibits tumor formation.Characteristics of chronic lymphocytic leukemia in SenegalEpigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2'-deoxycytidineQuantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemiaChronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomicsUrinary miR-16 transactivated by C/EBPβ reduces kidney function after ischemia/reperfusion-induced injury.Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia
P2860
Q24614789-AB3B60EE-E82A-4C6B-A700-C91171F456EEQ24618669-68A159C8-45BA-45EC-99F1-1F0915D0851BQ24633394-59584646-6A23-4D77-8978-F7ABEBD497A1Q26851604-8CD88B26-A42F-4B40-9AFB-7FD4C903EB8CQ27024411-3BF9B11D-923E-42C1-99E9-3ABD2843F5A0Q28388451-13CB17F1-3428-4630-902D-1BB1500682B0Q28395222-A2157DE6-AB66-4E3A-94AD-3010398181EFQ28603678-DA35D92C-AB76-4C54-BCA9-CD27AA4893FAQ33350258-547B5A3F-8A8A-45A0-BBC8-1508B449C4C6Q33426999-53597973-327E-4037-890C-594C082F06DEQ33452882-129F5C67-4506-4E4F-B582-BC68D9634567Q33638819-8A76361C-DAFC-4BE0-8C07-D422AE51D7C5Q33675704-622C9606-4693-4B41-A1B3-A20CAD7BE8C6Q33744997-E181E3C6-6B78-4782-9AB8-BACFA78D3E53Q33856215-CFFA8F43-8552-4DFE-94DE-24815C0D2858Q33954625-3C005786-671D-4147-BACC-A3F99E5F5072Q34065032-CCD80035-062A-4708-9A33-D95098C16023Q34195072-A0E57858-C4A7-44AE-B045-A26CBC177780Q34281240-181525B3-F235-430C-A1D7-51401B8E14BBQ34450715-EE9FB90B-9470-4033-9D27-8DFDFADE80FDQ34612039-A7E74083-C66A-4ADF-BD01-97D0BB6C886CQ34671934-E7E9BD01-BCDE-4B7E-99D8-231D50073827Q34917625-69626804-12FF-4E1F-96A4-A2CED09B0D12Q35011051-38C83CDB-71F4-4DAB-9A8D-1C0DFF821409Q35143490-FD0418D7-97FF-4472-80A4-B27CD9BF497EQ35510770-40F95C92-B41E-4464-AA97-0E52662EAB26Q35643026-8F7D88B2-7076-44E6-B853-9ACC71028735Q35742539-65870DBF-B383-4C39-BCEA-5B41BA71F33DQ35747814-7A4D08E3-BD52-48E0-A594-0422D8026E6DQ35751275-630DED26-156B-445D-A1DF-F06F3CF4E854Q35983641-2501BE08-42AB-4D5C-BD05-AF576239790DQ35997917-A983554B-D984-4DC8-AE57-CEA137A74FD9Q36166026-68518F51-5D45-43BA-82E5-80C62CDEA9FFQ36421804-077899A8-3705-4E15-9DDD-326B32507CA4Q36433299-0351ADB6-E614-4869-8357-C55CEE65CB30Q36651908-30995171-8C2D-442B-94CF-37DB81FC5C6DQ36906625-AD6F6758-5F09-41E7-96F5-C8A6DD5643CFQ36998431-123E870B-96D9-4639-8BB2-1F01A3672DA1Q37000636-BDB530E1-0DF5-467F-8F26-9760F596EF8DQ37037294-C0342D21-4E28-4EA2-9F54-1580DBE4A1B3
P2860
Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Integrated genomic profiling o ...... es subtypes of deletion 13q14.
@en
type
label
Integrated genomic profiling o ...... es subtypes of deletion 13q14.
@en
prefLabel
Integrated genomic profiling o ...... es subtypes of deletion 13q14.
@en
P2093
P1433
P1476
Integrated genomic profiling o ...... es subtypes of deletion 13q14.
@en
P2093
Harry Erba
Kerby Shedden
Lisa Kujawski
Mark Kaminski
Peter Ouillette
Sami N Malek
P304
P356
10.1158/0008-5472.CAN-07-3105
P407
P577
2008-02-01T00:00:00Z